The expression of MGMT is partly determined by the CpG methylation status of the promoter region of the MGMT gene—promoter hypermethylation leads to decreased expression of the MGMT protein and correlates with prolonged survival of GBM patients [9]. Here, MGMT is linked to glioblastoma.